ALGN

$153.202.21%3.3125

Align Technology Inc (ALGN)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$149.89

Offen:

$153.40

24-Stunden-Volumen:

467,890

Relatives Volumen:

0.44

Marktkapitalisierung:

$10.88B

Einnahmen:

$4.10B

Nettoeinkommen (Verlust:

$429.89M

KGV:

25.68

EPS:

$5.97

Netto-Cashflow:

$583.65M

1W Leistung:

+0.62%

1M Leistung:

+6.58%

6M Leistung:

-14.37%

1Y Leistung:

+11.11%

1-Tages-Spanne:

$150.28$154.65

1-Wochen-Bereich:

$147.52$156.50

52-Wochen-Spanne:

$130.23$200.44

Align Technology Inc Aktie (ALGN) Unternehmensprofil

Firmenname

Align Technology Inc

Sektor

Healthcare

Branche

Medical Instruments & Supplies

Telefon

408-470-1000

Adresse

410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE, CA, USA

Mitarbeiter

20,290

@AlignTechInc

Nächster Verdiensttermin

null

Neueste SEC-Einreichungen

SEC

ALGN-Diskussionen auf X

ALGN vs. ISRG, BDX, ALC, RMD, MDLN vergleichen

Aktien	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ALGN Align Technology Inc	$10.88B	$4.14B	$413.58M	$583.65M	$5.97
ISRG Intuitive Surgical Inc	$154.59B	$11.58B	$2.96B	$3.22B	$8.73
BDX Becton Dickinson Co	$54.20B	$20.84B	$941.00M	$3.07B	$3.94
ALC Alcon Inc	$35.56B	$224.23M	-$39.99M	$1.59B	$1.66
RMD Resmed Inc	$32.54B	$5.73B	$1.59B	$1.74B	$10.37
MDLN Medline Inc	$29.59B	$29.14B	$1.07B	$1.05B	$1.20

Align Technology Inc Aktie (ALGN) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-10-15	Herabstufung	Robert W. Baird	Outperform → Neutral
2026-10-05	Herabstufung	Evercore ISI	Outperform → In-line
2026-07-09	Eingeleitet	BMO Capital Markets	Outperform
2026-04-15	Eingeleitet	Citigroup	Buy
2026-03-17	Hochstufung	Barclays	Equal Weight → Overweight
2026-02-09	Hochstufung	HSBC Securities	Hold → Buy
2025-12-09	Eingeleitet	Barclays	Equal Weight
2025-10-10	Herabstufung	Jefferies	Buy → Hold
2025-07-31	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2025-04-25	Herabstufung	HSBC Securities	Buy → Hold
2025-02-14	Eingeleitet	Wells Fargo	Overweight
2025-01-06	Hochstufung	Leerink Partners	Market Perform → Outperform
2024-12-04	Eingeleitet	Mizuho	Outperform
2024-10-10	Eingeleitet	Needham	Hold
2024-02-26	Eingeleitet	Leerink Partners	Market Perform
2023-12-11	Herabstufung	Goldman	Neutral → Sell
2023-10-27	Herabstufung	UBS	Buy → Neutral
2023-02-02	Hochstufung	Goldman	Sell → Neutral
2022-07-28	Herabstufung	Goldman	Buy → Sell
2022-01-31	Eingeleitet	Morgan Stanley	Overweight
2022-01-31	Hochstufung	UBS	Neutral → Buy
2021-10-01	Resumed	Credit Suisse	Outperform
2021-08-05	Resumed	Credit Suisse	Outperform
2021-07-09	Hochstufung	Stephens	Equal-Weight → Overweight
2021-07-08	Eingeleitet	Exane BNP Paribas	Outperform
2021-04-22	Hochstufung	Berenberg	Hold → Buy
2021-01-04	Hochstufung	Evercore ISI	In-line → Outperform
2020-07-29	Herabstufung	Berenberg	Buy → Hold
2020-07-20	Herabstufung	BofA Securities	Neutral → Underperform
2020-01-09	Hochstufung	Wolfe Research	Peer Perform → Outperform
2019-10-24	Bestätigt	BofA/Merrill	Neutral
2019-10-07	Herabstufung	Guggenheim	Buy → Neutral
2019-07-25	Herabstufung	Evercore ISI	Outperform → In-line
2019-05-30	Eingeleitet	Wolfe Research	Peer Perform
2019-04-18	Eingeleitet	Guggenheim	Buy
2019-02-14	Herabstufung	UBS	Buy → Neutral
2019-01-17	Eingeleitet	UBS	Buy
2018-11-20	Bestätigt	Credit Suisse	Outperform
2018-07-26	Bestätigt	Stifel	Buy
2018-07-13	Bestätigt	Stifel	Buy
2018-06-25	Resumed	BofA/Merrill	Buy
2018-05-22	Bestätigt	Stifel	Buy
2018-05-17	Eingeleitet	Evercore ISI	Outperform
2018-04-26	Bestätigt	Stifel	Buy
2018-04-20	Eingeleitet	Berenberg	Buy
2018-04-19	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2018-03-08	Eingeleitet	Barclays	Overweight

Finanzdaten der Align Technology Inc-Aktie (ALGN)

Zeitraum	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Enddatum des Zeitraums	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	4,034.96	3,999.01	3,862.26	3,734.64	3,952.58
Cost of revenue USD (M)	1,323.95	1,199.85	1,155.40	1,100.86	1,017.23
Gross profit USD (M)	2,711.01	2,799.16	2,706.86	2,633.78	2,935.36
Research and development USD (M)	369.91	364.20	346.83	305.26	250.32
Operating expenses USD (M)	2,165.26	2,191.53	2,063.53	1,991.18	1,958.96
Operating income USD (M)	545.76	607.63	643.34	642.60	976.40
Income before tax USD (M)	585.29	608.96	641.20	599.06	1,012.42
Income tax expense USD (M)	174.94	187.60	196.15	237.48	240.40
Net income USD (M)	410.35	421.36	445.05	361.57	772.02
Basic EPS USD/shares	5.66	5.63	5.82	4.62	9.78
Diluted EPS USD/shares	5.65	5.62	5.81	4.61	9.69
Basic weighted shares shares (M)	72.54	74.88	76.43	78.19	78.92
Diluted weighted shares shares (M)	72.59	74.99	76.57	78.42	79.67
Selling, general and administrative USD (M)	1,755.79	1,763.19	1,703.38	1,674.47	1,708.64

Align Technology Inc-Aktie (ALGN) Insiderhandel

SIEGEL SUSAN EMay 20 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,745
Wert ($)
0
#Aktien Gesamt
10,723
Saia Andrea LynnMay 20 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,745
Wert ($)
0
#Aktien Gesamt
17,318
Poul MojdehMay 20 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,745
Wert ($)
0
#Aktien Gesamt
3,553
Myong AnneMay 20 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,745
Wert ($)
0
#Aktien Gesamt
9,830
LARKIN C RAYMOND JRMay 20 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
2,326
Wert ($)
0
#Aktien Gesamt
27,454
Dallas Kevin JMay 20 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,745
Wert ($)
0
#Aktien Gesamt
16,168
LACOB JOSEPHMay 20 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,745
Wert ($)
0
#Aktien Gesamt
135,916
Conroy Kevin TMay 20 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,745
Wert ($)
0
#Aktien Gesamt
3,553
MORROW GEORGE JMay 20 '26
Director
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,745
Wert ($)
0
#Aktien Gesamt
5,036
Morici JohnFeb 20 '26
EVP, CHIEF FINANCIAL OFFICER
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
7,848
Wert ($)
0
#Aktien Gesamt
16,085

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	#Aktien Gesamt
SIEGEL SUSAN E	Director	May 20 '26	Option Exercise	$0.00	1,745	10,723
Saia Andrea Lynn	Director	May 20 '26	Option Exercise	$0.00	1,745	17,318
Poul Mojdeh	Director	May 20 '26	Option Exercise	$0.00	1,745	3,553
Myong Anne	Director	May 20 '26	Option Exercise	$0.00	1,745	9,830
LARKIN C RAYMOND JR	Director	May 20 '26	Option Exercise	$0.00	2,326	27,454
Dallas Kevin J	Director	May 20 '26	Option Exercise	$0.00	1,745	16,168
LACOB JOSEPH	Director	May 20 '26	Option Exercise	$0.00	1,745	135,916
Conroy Kevin T	Director	May 20 '26	Option Exercise	$0.00	1,745	3,553
MORROW GEORGE J	Director	May 20 '26	Option Exercise	$0.00	1,745	5,036
Morici John	EVP, CHIEF FINANCIAL OFFICER	Feb 20 '26	Option Exercise	$0.00	7,848	16,085

Align Technology Inc Aktie (ALGN) Neueste Nachrichten

Nov 01, 2026

Tempe-based Invisalign maker brings in former Proctor & Gamble exec as CEO - The Business Journals

Nov 01, 2026

Align Technology, Inc. (AFW.F) Seasonal Returns Chart - Yahoo! Finance Canada

Nov 01, 2026

Oct 31, 2026

5 insightful analyst questions from Align Technology’s Q3 earnings call - Yahoo Finance

Oct 31, 2026

Oct 30, 2026

Align Technology (ALGN) Stock Sees Modest Fair Value Cut As Analyst Views Split - Yahoo! Finance Canada

Oct 30, 2026

Align Technology Inc. stock outperforms competitors despite losses on the day - MarketWatch

Oct 30, 2026

Align Technology: The Competitive Threat Has Eased, But Growth Remains A Concern (ALGN) - Seeking Alpha

Oct 30, 2026